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METHODS
• Sequential linear regression analysis conducted on 
health and demographic data, using two validated 
anxiety/depression scales combined [Patient Health 
Questionnaire (PHQ-9) and Generalized Anxiety 
Disorder (GAD-7)] as the primary outcome.
• Demographic characteristics (body mass index 
[BMI] age and gender) was recorded on patients. 
The presence or absence of various co-morbidities -
hypertension, sleep apnoea, diabetes, ischaemic 
heart disease (IHD), arthritis, anxiety/depression, 
COPD/asthma and hypothyroidism - was also 
recorded for all patients. 
• Individual and summed item scores on the PHQ-9
and GAD-7 instruments were also recorded; with 
the key outcome variables considered to be the 
summed scale scores.
• The sample was summarised descriptively. The 
extent of missing data, and its suitability for 
imputation, was assessed before analysis. Cases 
with extensive missing data were deleted from the 
data set before further analysis.
• The correlation and level of agreement between the 
PHQ-9 and GAD-7 summed scale scores was 
assessed. As both these measures comprised 
similarly worded outcomes, with identical response 
options and option scoring, it was considered 
appropriate to derive a composite measure from the 
two scales for use in a subsequent regression 
analysis, subject to findings of high correlation and 
good consistency between the scales.
• The impact of demographic characteristics and co-
morbidities was assessed on the combined 
outcome measure using a sequential modelling 
strategy, using 2 blocks; comprising respectively all 
co-morbidity variables (Block 1) and all 
demographic variables (Block 2). Within Block 1, a 
backward elimination modelling strategy was 
utilised to derive a parsimonious subset of variables 
to be considered in conjunction with demographic 
variables, all of which, being of greater clinical 
interest, were forced into the model in Block 2. 
Standard regression statistics for the final model 
were reported.
• Regression assumptions were checked using 
residual plots. Standardised residuals, leverage 
values and Cook’s distances were derived for all 
data points to check for the presence of values 
exerting an undue influence on the regression 
model.
INTRODUCTION
• Aim: To determine if co-morbidities have an 
effect on mood in a cohort of morbidly 
obese patients.
CONCLUSIONS
• PHQ9 and GAD7 scales are closely correlated and show good agreement with each other. Hence 
analysis was conducted on a single outcome measure combined from both of these scales.
• There is insufficient evidence to conclude that either BMI or gender affect scores measured on the 
combined PHQ9/GAD7 outcome. 
• Some substantive association (non-significant) appears to exist between age and combined scale 
scores; with older patients reporting slightly better functionality.
• Of the various co-morbidities reported by patients, arthritis and, particularly, reported 
anxiety/depression have the greatest effect on combined scale scores. The presence of both these 
conditions is associated with lower functionality.
• There is no evidence that the presence of any other co-morbidity affects the combined scale scores.
• There is no evidence for violation of model assumptions or of any individual data point exerting undue 
influence on the model.
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RESULTS
• Outcome data was collected on 464 patients. However, no demographic or co-morbidity data was collected on 54 patients. These patients were deleted from further analysis, leaving 410 patients for analysis. About 0.1% of data 
on the remaining cases was missing, with complete information available from 406 cases. Imputation was not conducted on the missing data.
• Seventy nine patients (19.4%) had no reported co-morbidities. About half of all patients (211; 51.4%) had 1 or 2 reported co-morbidities; of which hypertension and anxiety/depression were the most common.  One hundred and 
seventeen patients (28.7%) reported 3 or more co-morbidities. The number of reported co-morbidities was linked with age; with older patients were likely to report more co-morbidities (r=0.443; p<0.001). Men reported more co-
morbidities than women (mean number of co-morbidities reported by men=2.14 (SD=1.93); mean number of co-morbidities reported by women=1.71 (SD=1.32)). There was no relationship between BMI and number of reported 
co-morbidities; or between any of the reported demographic variables and either outcome score.  The sample is summarised descriptively in Table 1.
• The outcome measures of PHQ-9 and GAD-7 were found to be strongly and significantly correlated (r=0.822; p<0.001). The extent of the correlation suggested that a multivariate analysis or independent regression analyses 
conducted on the separate scale scores would be of limited benefit; furthermore, independent regression analyses could lead to inflated familywise error rates. hence analysis was conducted on a combined outcome. 
• A Bland-Altman plot derived from the two sets of standardised scores (Figure 1) illustrated good levels of agreement between the scales, with no obvious relationship between agreement level and scale scores. Hence a simple 
composite measure comprising the unweighted total of item scores of both scales was derived for use in a subsequent regression analysis.
• The sequential regression analysis conducted on the combined outcome measure resulted in variables corresponding to patient anxiety/depression and arthritis being carried forward from Block 1 of the sequential regression 
analysis for inclusion in the final model alongside the demographic variables. In this model, occurrence of arthritis and occurrence of anxiety/depression were both statistically significant at the 5% significance level (p=0.049 for 
occurrence of arthritis; p<0.001 for occurrence of anxiety/depression), with the presence of both conditions being associated with lower functionality. 
• Age appeared to show some substantive association with the outcome (p=0.069); the negative parameter coefficient implies that functionality increases with increasing age (for both of the individual scales, and the combined 
scale, higher scores indicate lower functionality). BMI and gender did not exhibit any relationship with the outcome measure; with increasing age being associated with slightly improved functionality. 
• BMI, gender and the presence of other co-morbidities, including diabetes, did not exhibit any substantive relationship with the outcome measure.
• P-values and parameter estimates with associated 95% confidence intervals (CIs) for all variables in the final model are given in Table 2. 
• Controlling for other variables in the final model, a patient with arthritis would score on average 3.15 points more on the combined PHQ9/GAD7 scale than a patient without arthritis (indicating worsening functionality). A patient 
with anxiety/depression would score on average 7.23 points more on the combined PHQ9/GAD7 scale than a patient without anxiety/depression (also indicating worsening functionality). 
• The adjusted-R2 statistic for this model was 0.075, indicating that the model is a fairly good fit to the data. 
• Examination of a plot of standardised residuals against standardised predicted values revealed no violations of regression assumptions (Figure 2).
• The largest absolute value of the standardised residuals was found to be 2.13; well within expectations for a data set of this size. The largest leverage value recorded for any data point was 0.045; about on the limit of 
expectations for a data set of this size. However, the largest value of Cook’s distances recorded for any data point was 0.018, suggesting that no individual data point exerted undue influence on the model.
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Table 1: descriptive summary of sample (n=410)
BACKGROUND
• A significant proportion of adults diagnosed with 
type 2 diabetes will also have concomitant obesity, 
currently defined as people with a body mass index 
(BMI) of > 30 (Gregg et al. 2007).
• This combination of concomitant risk (obesity and 
type 2 diabetes) has been termed by some 
clinicians as the ‘diabesity’ epidemic (Zimmett 
2007, Bailey 2009).
• Current research and evidence-based practice 
guidelines offer a range of treatments and care 
pathways for reducing obesity +/- type 2 diabetes.
• Prior  recent research in the morbidly obese 
(selected) has examined  mental health status and 
coping mediators related to functionality (Aarts et 
al. 2014), personal factors associated with QoL 
(Lerdal et al. 2011), and the relationship of mood to 
health related quality of life measures (Andanaes et 
al.  2012).  However none of these studies have 
examined associations of  mental health indicators 
in relation to the presence of type 2 diabetes.
Figure 1: Bland-Altman plot for agreement between PHQ9 and GAD7 outcomes
Table 2: P-values, parameter estimates and confidence intervals: combined PHQ9/GAD7 outcome
Figure 2: residual plot for final model
Categorical variable Frequency (valid %)
Gender
Male
Female
111 (27.2%)
297 (72.8%)
Hypertension reported
Yes
No
136 (33.2%)
274 (66.8%)
Sleep apnoea reported
Yes
No
76 (18.5%)
334 (81.5%)
Diabetes reported
Yes
No
107 (26.1%)
303 (73.9%)
IHD reported
Yes
No
21 (5.1%)
389 (94.9%)
Arthritis reported
Yes
No
98 (23.9%)
312 (76.1%)
Anxiety/depression reported
Yes
No
178 (43.4%)
232 (56.6%)
COPD/asthma reported
Yes
No
101 (24.8%)
307 (75.2%)
Hyperthyroidism reported
Yes
No
34 (8.3%)
375 (91.7%)
Numerical variable Mean (SD)
BMI (kgm-2) 46.8 (8.02)
Age (years) 47.3 (12.7)
PHQ-9 total score 12.4 (7.37)
GAD-7 total score 8.68 (6.54)
Variable p-value Parameter estimate 95% CI
Arthritis 0.048 3.15 (0.027, 6.28)
Anxiety/depression <0.001 7.23 (4.68, 9.78)
BMI 0.217 0.103 (-0.061, 0.266)
Gender1 0.410 -1.21 (-4.08, 1.67)
Age 0.069 -0.099 (-0.206, 0.088)
